SEC Form 3 · accession 0001209191-16-147039
Myovant Sciences Ltd. · MYOV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Wayne S DeVeydt
Director
Period of report
Oct 26, 2016
Accepted (ET)
Oct 26, 2016 · 8:13 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001679082
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Shares | holding | — | — | — | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $5.11 | holding | — | — | — | — | Sep 20, 2026 | Common Shares | 42,308 | — | D |
Explanation of responses
- F11/3rd of the shares underlying the option shall vest and become exercisable on September 21, 2017; the balance of the shares shall vest and become exercisable in a series of eight (8) successive equal quarterly installments measured from September 21, 2017, subject to the Reporting Person providing continuous service to the Issuer on each such date.
Remarks
Exhibit List - Exhibit 24 - Power of Attorney